Andrographolide, a novel NF-κB inhibitor, inhibits vascular smooth muscle cell proliferation and cerebral endothelial cell inflammation

Acta Cardiologica Sinica

Volumn 30, Issue 4, 2014, Pages 308-315

  Chang, Chao Chien ^a,b   Duann, Yeh Fang ^c   Yen, Ting Lin ^b,d   Chen, Yu Ying ^b,d   Jayakumar, Thanasekaran ^b,d   Ong, Eng Thiam ^a   Sheu, Joen Rong ^b,d  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIPEI UNIVERSITY OF TECHNOLOGY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Andrographolide; CECs; COX2 iNOS; ERK PCNA; LPS; PDGF BB; VSMCs

Indexed keywords

ANDROGRAPHOLIDE; ANTIINFLAMMATORY AGENT; CYCLINE; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PLATELET DERIVED GROWTH FACTOR BB;

ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CAPILLARY ENDOTHELIAL CELL; CELL COUNT; CELL ISOLATION; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; INFLAMMATION; MALE; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

EID: 84907287262     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011;4:104-11.
2. Sachinidis A, Locher R, Vetter W, et al. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem 1990;265:10238-43.
3. Bornfeldt KE, Raines EW, Graves LM, et al. Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci 1995;766:416-30.
4. Faraci FM, Lentz SR. Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 2004;35:345-7.
5. Coleman HA, Tare M, Parkington HC. Endothelial potassium channels, endothelium-dependent hyperpolarization and the regulation of vascular tone in health and disease. Clin Exp Pharmacol Physiol 2004;31:641-9.
6. Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Med 2004;70:293-8.
7. Bao Z, Guan S, Cheng C, et al. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med 2009;179:657-65.
8. Yang T, Shi HX, Wang ZT, Wang CH. Hypolipidemic effects of andrographolide and neoandrographolide in mice and rats. Phytother Res 2013;27:618-23.
9. Chiou WF, Chen CF, Lin JJ. Mechanisms of suppression of inducible nitric oxide synthase (iNOS) expression in RAW 264.7 cells by andrographolide. Br J Pharmacol 2000;129:1553-60.
10. Chang HM, Pui-Hay But P. Pharmacology and Applications of Chinese Materia Medica, Vol. 2,World Scientific, Singapore, 1987.
11. Calabrese C, Berman SH, Babish JG, et al. A phase I trial of andrographolide in HIV positive patients and normal volunteers. Phytother Res 2000;14:333-8.
12. Uttekar MM, Das T, Pawar RS, et al. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. Eur J Med Chem 2012; 56:368-74.
13. Veeresham C, Swetha E, Rao AR, Asres K. In vitro and in vivo aldose reductase inhibitory activity of standardized extracts and the major constituent of Andrographis paniculata. Phytother Res 2013;27:412-6.
14. Lu WJ, Lee JJ, Chou DS, et al. A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP. J Mol Med (Berl) 2011;89:1261-73.
15. Lu WJ, Lin KH, Hsu MJ, et al. Suppression of NF-kB signaling by andrographolide with a novel mechanism in human platelets: regulatory roles of the p38MAPK-hydroxyl radical-ERK2 cascade. Biochem Pharmacol 2012;84:914-24.
16. Hsieh CY, Hsu MJ, Hsiao G, et al. Andrographolide enhances nuclear factor-kappaB subunit p65 Ser536 dephosphorylation through activation of protein phosphatase 2A in vascular smooth muscle cells. J Biol Chem 2011;286:5942-55.
17. Lien LM, Su CC, Hsu WH, et al. Mechanisms of andrographolide-induced platelet apoptosis in human platelets: regulatory roles of the extrinsic apoptotic pathway. Phytother Res 2013;27: 1671-7.
18. Jayakumar T, Hsieh CY, Lee JJ, et al. Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evid Based Complement Alternat Med 2013;2013:846740.
19. Hsiao G, Shen MY, Chang WC, et al. A novel antioxidant, octyl caffeate, suppression of LPS/IFN-gamma-induced inducible nitric oxide synthase gene expression in rat aortic smooth muscle cells. Biochem Pharmacol 2003;65:1383-92.
20. Wu Z, Hofman FM, Zlokovic BV. A simple method for isolation and characterization of mouse brain microvascular endothelial cells. J Neurosci Methods 2003;130:53-63.
21. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
22. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;62:801-9.
23. Schwartz SM. Smooth muscle migration in atherosclerosis and restenosis. J Clin Invest 1997;100:S87-9.
24. Nguyen Dinh Cat A, Montezano AC, Burger D, et al. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox Signal 201;19:1110-20.
25. Yoo AR, Koh SH, Cho GW, Kim SH. Inhibitory effects of cilostazol on proliferation of vascular smooth musclecells (VSMCs) through suppression of the ERK1/2 pathway. J Atheroscler Thromb 2010;17:1009-18.
26. Mulvany MJ. Structure and function of small arteries in hypertension. J Hypertens Suppl 1990;8:S225-32.
27. Ross R. Cell biology of atherosclerosis. Annu Rev Physiol 1995; 57:791-804.
28. Kim TJ, Yun YP. Antiproliferative activity of NQ304, a synthetic 1,4-naphthoquinone, is mediated via the suppressions of the PI3K/Akt and ERK1/2 signaling pathways in PDGF-BB-stimulated vascular smoothmuscle cells. Vascular Pharmacol 2007;46:43-51.
29. Gennaro G, Menard C, Michaud SE, et al. Inhibition of vascular smooth muscle cell proliferation and neointima formation in injured arteries by a novel, oral mitogen-activated protein kinase/ extracellular signal-regulated kinase inhibitor. Circulation 2004; 110:3367-71.
30. Lavezzi AM, Ottaviani G, Matturri L. Biology of the smooth muscle cells in human atherosclerosis. APMIS 2005;113:112-21.
31. Zhang F, Sun AS, Yu LM, et al. Effects of isorhynchophylline on angiotensin II-induced proliferation in rat vascular smooth muscle cells. J Pharm Pharmacol 2008;60:1673-8.
32. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-6.
33. Griswold DE, Adams JL. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med Res Rev 1996;16:181-206.
34. Gong C, Ennis SR, Hoff JT, Keep RF. Inducible cyclooxygenase-2 expression after experimental intracerebral hemorrhage. Brain Res 2001;901:38-46.
35. Forster C, Clark HB, Ross ME, Iadecola C. Inducible nitric oxide synthase expression in human cerebral infarcts. Acta Neuropathol 1999;97:215-20.
36. Keynes RG, Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 2004;4:179-91.